lxy888的个人主页 - 老虎社区

lxy888

lxy888

暂无个人介绍

IP属地：未知

8关注

0粉丝

0主题

0勋章

2022-02-16

Gd

抱歉，原内容已删除

2022-02-16

"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows."

抱歉，原内容已删除

2022-02-15

Great ariticle, would you like to share it?

抱歉，原内容已删除

2022-02-12

👏

China Approves Use of Pfizer's COVID Drug Paxlovid

2022-02-08

$STI ETF(ES3.SI)$a stock to buy and monitor

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3581829028595571,"uuid":"3581829028595571","gmtCreate":1618735340948,"gmtModify":1643205075740,"name":"lxy888","pinyin":"lxy888","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":638029871,"gmtCreate":1644996718418,"gmtModify":1644997633933,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/638029871","repostId":"2211563955","repostType":4,"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638020554,"gmtCreate":1644996589792,"gmtModify":1644996724313,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","listText":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","text":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638020554","repostId":"2211563955","repostType":2,"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631484618,"gmtCreate":1644893368586,"gmtModify":1644893368586,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/631484618","repostId":"2211000683","repostType":2,"isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631689420,"gmtCreate":1644644000839,"gmtModify":1644644000839,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"👏","listText":"👏","text":"👏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/631689420","repostId":"2210409526","repostType":4,"repost":{"id":"2210409526","pubTimestamp":1644633920,"share":"https://www.laohu8.com/m/news/2210409526?lang=&edition=full","pubTime":"2022-02-12 10:45","market":"us","language":"en","title":"China Approves Use of Pfizer's COVID Drug Paxlovid","url":"https://stock-news.laohu8.com/highlight/detail?id=2210409526","media":"Reuters","summary":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditi","content":"<html><head></head><body><p>BEIJING, Feb 12 (Reuters) - China&#39;s medical products regulator said on Saturday it has given conditional approval for Pfizer&#39;s COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.</p><p>The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.</p><p>It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. </p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Approves Use of Pfizer's COVID Drug Paxlovid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Approves Use of Pfizer's COVID Drug Paxlovid\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-12 10:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","PFE":"辉瑞","BK4124":"机动车零配件与设备","BK4534":"瑞士信贷持仓"},"source_url":"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2210409526","content_text":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633780783,"gmtCreate":1644324458333,"gmtModify":1644324458333,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>a stock to buy and monitor","listText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>a stock to buy and monitor","text":"$STI ETF(ES3.SI)$a stock to buy and monitor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633780783","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":631689420,"gmtCreate":1644644000839,"gmtModify":1644644000839,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"👏","listText":"👏","text":"👏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/631689420","repostId":"2210409526","repostType":4,"repost":{"id":"2210409526","pubTimestamp":1644633920,"share":"https://www.laohu8.com/m/news/2210409526?lang=&edition=full","pubTime":"2022-02-12 10:45","market":"us","language":"en","title":"China Approves Use of Pfizer's COVID Drug Paxlovid","url":"https://stock-news.laohu8.com/highlight/detail?id=2210409526","media":"Reuters","summary":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditi","content":"<html><head></head><body><p>BEIJING, Feb 12 (Reuters) - China&#39;s medical products regulator said on Saturday it has given conditional approval for Pfizer&#39;s COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.</p><p>The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.</p><p>It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment. </p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Approves Use of Pfizer's COVID Drug Paxlovid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Approves Use of Pfizer's COVID Drug Paxlovid\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-12 10:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","PFE":"辉瑞","BK4124":"机动车零配件与设备","BK4534":"瑞士信贷持仓"},"source_url":"https://finance.yahoo.com/news/1-china-approves-pfizers-covid-024520927.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2210409526","content_text":"BEIJING, Feb 12 (Reuters) - China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 treatment Paxlovid, making it the first oral anti-coronavirus pill approved in the country to treat the disease.The National Medical Products Administration said Paxlovid has obtained conditional approval to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and submitted to the authority, it said.It is not immediately clear if China is already in talks with Pfizer to procure the pill. Pfizer did not reply to a Reuters request for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638029871,"gmtCreate":1644996718418,"gmtModify":1644997633933,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Gd","listText":"Gd","text":"Gd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/638029871","repostId":"2211563955","repostType":4,"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":638020554,"gmtCreate":1644996589792,"gmtModify":1644996724313,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","listText":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","text":"\"By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.\"","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/638020554","repostId":"2211563955","repostType":2,"repost":{"id":"2211563955","pubTimestamp":1644969658,"share":"https://www.laohu8.com/m/news/2211563955?lang=&edition=full","pubTime":"2022-02-16 08:00","market":"us","language":"en","title":"3 Growth Stocks Down 20% to 77% to Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2211563955","media":"Motley Fool","summary":"Low prices could be a value trap, but these definitely spell opportunity.","content":"<html><head></head><body><p>It hasn&#39;t been a great year so far for growth stocks. After massive valuation spikes and general macroeconomic upheaval, investors have been shifting their money into value stocks. That&#39;s leaving many excellent stocks on the table, withering in value even as they manage effective businesses and offer high potential for reward.</p><p>The tide will turn at some point, and that spells opportunity for forward-thinking investors. If you focus on the long term, you&#39;ll find great investing options that offer a low entry point, making the potential for gains even greater. We asked three Motley Fool contributors for their top choices, and <b>Walt Disney</b> (NYSE:DIS), <b>fuboTV</b> (NYSE:FUBO), and <b>Netflix</b> (NASDAQ:NFLX) made the cut. They&#39;re all down over the past year,  and smart investors will take the chance to buy on the dip.</p><h2>Disney: Down 20% over one year</h2><p><b>Jennifer Saibil (Disney):</b> Disney&#39;s business has been ping-ponging back and forth since the pandemic started, a big departure from its more typical solid performance as the biggest entertainment company in the world. When parks were closed, Disney+ carried the company through, then parks rebounded and streaming slowed down. In the latest numbers, the 2022 fiscal first quarter (ended Jan. 1) demonstrated good news all around, and this might just be the end of the tunnel for investors.</p><p>In the 2021 fourth quarter, investors were disappointed in the light subscriber additions for Disney+. At the time, management wasn&#39;t worried, and reassured investors that it was on track for subscriber additions over time, although each quarter wouldn&#39;t be symmetrical. Disney regained investor confidence when that became true in the first quarter, and Disney+ added 11.7 million more subscribers than last quarter.</p><p>But that&#39;s just the beginning of Disney&#39;s amazing performance in the first quarter. It posted record total revenue of $21.8 billion, a 34% year-over-year increase. Earnings per share (EPS) from continuing operations came in at $0.63, up from $0.02 last year. EPS (excluding certain items) of $1.06 was up from $0.32 last year and beat average analyst expectations of $0.74.</p><p>&#34;This marks the final year of The Walt Disney Company&#39;s first century, and performance like this coupled with our unmatched collection of assets and platforms, creative capabilities, and unique place in the culture give me great confidence we will continue to define entertainment for the next 100 years,&#34; CEO Bob Chapek said.  With its unmatched content creation machines, parks, products, and more, investors should expect that as well.</p><p>Disney&#39;s price did rise on the beat, but it&#39;s still down over the past year, giving you the opportunity to get shares of this entertainment giant for a great price.</p><h2>fuboTV: Down 77% over one year</h2><p><b>Parkev Tatevosian (fuboTV):</b> fuboTV is a sports-centric streaming alternative to live TV. The company benefits from the trend of consumers preferring to stream their content. That tailwind is unlikely to reverse as streaming offers convenience and, most of the time, lower costs. Not to mention folks can enjoy a streaming live TV service anywhere they get an internet connection with a mobile device, a feature not possible with a cable TV connection.</p><p>fuboTV&#39;s revenue is snowballing. Indeed, in its most recently reported quarter, ended Sept. 30, 2021, fuboTV&#39;s revenue increased by 156% from the same quarter in the year before. It grew subscribers by 108% in that same time. In January, the company announced preliminary results for its fourth quarter, and again delivered robust growth in revenue and subscriber figures. Interestingly, fuboTV is not the only streaming alternative to live TV, but it outperforms its competitors. According to <b>Nielsen</b>, from the third quarter of 2020 to Q3 2021, when fuboTV grew subscribers by 108%, the rest of its industry grew by just 34%.</p><p>The results highlight that consumers gravitate toward fuboTV&#39;s sports-centric option, which makes sense. One of the primary reasons folks stick with live TV services is sports. So far, that&#39;s an excellent sign for fuboTV and its shareholders. And with an estimated 73 million households still on traditional pay-TV subscriptions in the U.S., fuboTV has plenty of runway for growth.</p><p>That&#39;s all well and good, but why is the stock down 77% in the past year? To put it simply, it costs more for fuboTV to serve its subscribers than it gets back in revenue. The company lost $106 million on the bottom line in Q3 on $156.7 million in revenue. As you might imagine, that business model is not sustainable, and something needs to change. Either fuboTV needs to charge more for its service, which could slow subscriber growth, or it needs to lower its expenses. Investors who take a chance on management&#39;s ability to figure this out stand to reap significant gains.</p><h2>Netflix: Down 29% over one year</h2><p><b>John Ballard (Netflix):</b> Netflix shares are 42% off recent highs, which presents a rare opportunity to buy this leading streamer on sale. Investors can blame slowing subscriber growth, which came in at 8.9% year over year in the fourth quarter. That is down from the 20%-plus rates we saw through 2020. But as sometimes happens, the market is taking an ultra-short-term view on this disruptive entertainment platform.</p><p>Global broadband and smart TV penetration are still growing around the world. But investors are underestimating how far into the future Netflix can add new subscribers. One analyst estimates that Netflix can hit 500 million subscribers by 2030, which would still be a small fraction of the global internet population of more than 5 billion.</p><p>Management&#39;s strategy to continue investing in content while guiding the business toward positive free cash flow beyond 2022 should drive shareholder returns. One near-term release that could change the market&#39;s mind is season four of <i>Stranger Things</i> coming this summer. By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks Down 20% to 77% to Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks Down 20% to 77% to Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-16 08:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/15/3-growth-stocks-down-20-to-77-to-buy-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It hasn't been a great year so far for growth stocks. After massive valuation spikes and general macroeconomic upheaval, investors have been shifting their money into value stocks. That's leaving many...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/15/3-growth-stocks-down-20-to-77-to-buy-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4548":"巴美列捷福持仓","BK4524":"宅经济概念","FUBO":"fuboTV Inc.","BK4551":"寇图资本持仓","BK4108":"电影和娱乐","BK4561":"索罗斯持仓","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","BK4077":"互动媒体与服务","NFLX":"奈飞","DIS":"迪士尼","BK4566":"资本集团","BK4550":"红杉资本持仓"},"source_url":"https://www.fool.com/investing/2022/02/15/3-growth-stocks-down-20-to-77-to-buy-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211563955","content_text":"It hasn't been a great year so far for growth stocks. After massive valuation spikes and general macroeconomic upheaval, investors have been shifting their money into value stocks. That's leaving many excellent stocks on the table, withering in value even as they manage effective businesses and offer high potential for reward.The tide will turn at some point, and that spells opportunity for forward-thinking investors. If you focus on the long term, you'll find great investing options that offer a low entry point, making the potential for gains even greater. We asked three Motley Fool contributors for their top choices, and Walt Disney (NYSE:DIS), fuboTV (NYSE:FUBO), and Netflix (NASDAQ:NFLX) made the cut. They're all down over the past year,  and smart investors will take the chance to buy on the dip.Disney: Down 20% over one yearJennifer Saibil (Disney): Disney's business has been ping-ponging back and forth since the pandemic started, a big departure from its more typical solid performance as the biggest entertainment company in the world. When parks were closed, Disney+ carried the company through, then parks rebounded and streaming slowed down. In the latest numbers, the 2022 fiscal first quarter (ended Jan. 1) demonstrated good news all around, and this might just be the end of the tunnel for investors.In the 2021 fourth quarter, investors were disappointed in the light subscriber additions for Disney+. At the time, management wasn't worried, and reassured investors that it was on track for subscriber additions over time, although each quarter wouldn't be symmetrical. Disney regained investor confidence when that became true in the first quarter, and Disney+ added 11.7 million more subscribers than last quarter.But that's just the beginning of Disney's amazing performance in the first quarter. It posted record total revenue of $21.8 billion, a 34% year-over-year increase. Earnings per share (EPS) from continuing operations came in at $0.63, up from $0.02 last year. EPS (excluding certain items) of $1.06 was up from $0.32 last year and beat average analyst expectations of $0.74.\"This marks the final year of The Walt Disney Company's first century, and performance like this coupled with our unmatched collection of assets and platforms, creative capabilities, and unique place in the culture give me great confidence we will continue to define entertainment for the next 100 years,\" CEO Bob Chapek said.  With its unmatched content creation machines, parks, products, and more, investors should expect that as well.Disney's price did rise on the beat, but it's still down over the past year, giving you the opportunity to get shares of this entertainment giant for a great price.fuboTV: Down 77% over one yearParkev Tatevosian (fuboTV): fuboTV is a sports-centric streaming alternative to live TV. The company benefits from the trend of consumers preferring to stream their content. That tailwind is unlikely to reverse as streaming offers convenience and, most of the time, lower costs. Not to mention folks can enjoy a streaming live TV service anywhere they get an internet connection with a mobile device, a feature not possible with a cable TV connection.fuboTV's revenue is snowballing. Indeed, in its most recently reported quarter, ended Sept. 30, 2021, fuboTV's revenue increased by 156% from the same quarter in the year before. It grew subscribers by 108% in that same time. In January, the company announced preliminary results for its fourth quarter, and again delivered robust growth in revenue and subscriber figures. Interestingly, fuboTV is not the only streaming alternative to live TV, but it outperforms its competitors. According to Nielsen, from the third quarter of 2020 to Q3 2021, when fuboTV grew subscribers by 108%, the rest of its industry grew by just 34%.The results highlight that consumers gravitate toward fuboTV's sports-centric option, which makes sense. One of the primary reasons folks stick with live TV services is sports. So far, that's an excellent sign for fuboTV and its shareholders. And with an estimated 73 million households still on traditional pay-TV subscriptions in the U.S., fuboTV has plenty of runway for growth.That's all well and good, but why is the stock down 77% in the past year? To put it simply, it costs more for fuboTV to serve its subscribers than it gets back in revenue. The company lost $106 million on the bottom line in Q3 on $156.7 million in revenue. As you might imagine, that business model is not sustainable, and something needs to change. Either fuboTV needs to charge more for its service, which could slow subscriber growth, or it needs to lower its expenses. Investors who take a chance on management's ability to figure this out stand to reap significant gains.Netflix: Down 29% over one yearJohn Ballard (Netflix): Netflix shares are 42% off recent highs, which presents a rare opportunity to buy this leading streamer on sale. Investors can blame slowing subscriber growth, which came in at 8.9% year over year in the fourth quarter. That is down from the 20%-plus rates we saw through 2020. But as sometimes happens, the market is taking an ultra-short-term view on this disruptive entertainment platform.Global broadband and smart TV penetration are still growing around the world. But investors are underestimating how far into the future Netflix can add new subscribers. One analyst estimates that Netflix can hit 500 million subscribers by 2030, which would still be a small fraction of the global internet population of more than 5 billion.Management's strategy to continue investing in content while guiding the business toward positive free cash flow beyond 2022 should drive shareholder returns. One near-term release that could change the market's mind is season four of Stranger Things coming this summer. By the time Netflix dumps more content from its delayed production schedule over the next year, Netflix stock could look very undervalued at these lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":631484618,"gmtCreate":1644893368586,"gmtModify":1644893368586,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/631484618","repostId":"2211000683","repostType":2,"repost":{"id":"2211000683","pubTimestamp":1644892605,"share":"https://www.laohu8.com/m/news/2211000683?lang=&edition=full","pubTime":"2022-02-15 10:36","market":"us","language":"en","title":"Elon Musk Donated $5.7 Billion of Tesla Shares to Charity","url":"https://stock-news.laohu8.com/highlight/detail?id=2211000683","media":"Bloomberg","summary":"Elon Musk reported that he gifted almost $6 billion worth of Tesla Inc. shares to charity in Novembe","content":"<html><head></head><body><p>Elon Musk reported that he gifted almost $6 billion worth of Tesla Inc. shares to charity in November.</p><p>The world’s richest man donated more than 5 million shares in the electric automaker from Nov. 19 to Nov. 29, according to a filing with the Securities and Exchange Commission. The gift was worth about $5.7 billion, based on average prices the days he sold the stock, making it <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest to a charity in history. An unidentified trust was involved in the transaction, and the name of the charity wasn’t cited in the document.</p><p>The donation occurred as Musk, Tesla’s chief executive officer, battled with politicians including Bernie Sanders and Elizabeth Warren over inequality and a potential wealth levy. Around the same time, Musk suggested he’d sell stock if the United Nations could prove it would help solve world hunger after the head of the organization’s food-aid arm suggested billionaires like Musk should “step up now, on a one-time basis.”</p><p>A large gift to charity last year would help reduce what Musk claimed would be the biggest tax bill in U.S. history. Bloomberg calculated in December that Musk could owe more than $10 billion to the Internal Revenue Service, triggered by his exercise of an unusually large number of options in 2021.</p><p>Musk has an eponymous foundation that’s become more active over recent years, with large, eight-figure gifts promised to the city near his South Texas spaceport, a $100 million competition for carbon removal and $5 million to two scientists for Covid-19 research. Before then, his foundation’s largest contributions were to donor-advised funds, or DAFs, where charitable money can sit in perpetuity.</p><p>The Musk Foundation, which used to count Musk’s brother Kimbal as a director, has recently added a new face to its roster. Several grant recipients Bloomberg spoke with have said their primary point of contact at the foundation is Igor Kurganov, a professional poker player-turned-philanthropist who is active in the effective altruism space.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk Donated $5.7 Billion of Tesla Shares to Charity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk Donated $5.7 Billion of Tesla Shares to Charity\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-15 10:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/elon-musk-donated-5-7-022043174.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elon Musk reported that he gifted almost $6 billion worth of Tesla Inc. shares to charity in November.The world’s richest man donated more than 5 million shares in the electric automaker from Nov. 19 ...</p>\n\n<a href=\"https://finance.yahoo.com/news/elon-musk-donated-5-7-022043174.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BK4555":"新能源车","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4534":"瑞士信贷持仓","BK4527":"明星科技股"},"source_url":"https://finance.yahoo.com/news/elon-musk-donated-5-7-022043174.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2211000683","content_text":"Elon Musk reported that he gifted almost $6 billion worth of Tesla Inc. shares to charity in November.The world’s richest man donated more than 5 million shares in the electric automaker from Nov. 19 to Nov. 29, according to a filing with the Securities and Exchange Commission. The gift was worth about $5.7 billion, based on average prices the days he sold the stock, making it one of the biggest to a charity in history. An unidentified trust was involved in the transaction, and the name of the charity wasn’t cited in the document.The donation occurred as Musk, Tesla’s chief executive officer, battled with politicians including Bernie Sanders and Elizabeth Warren over inequality and a potential wealth levy. Around the same time, Musk suggested he’d sell stock if the United Nations could prove it would help solve world hunger after the head of the organization’s food-aid arm suggested billionaires like Musk should “step up now, on a one-time basis.”A large gift to charity last year would help reduce what Musk claimed would be the biggest tax bill in U.S. history. Bloomberg calculated in December that Musk could owe more than $10 billion to the Internal Revenue Service, triggered by his exercise of an unusually large number of options in 2021.Musk has an eponymous foundation that’s become more active over recent years, with large, eight-figure gifts promised to the city near his South Texas spaceport, a $100 million competition for carbon removal and $5 million to two scientists for Covid-19 research. Before then, his foundation’s largest contributions were to donor-advised funds, or DAFs, where charitable money can sit in perpetuity.The Musk Foundation, which used to count Musk’s brother Kimbal as a director, has recently added a new face to its roster. Several grant recipients Bloomberg spoke with have said their primary point of contact at the foundation is Igor Kurganov, a professional poker player-turned-philanthropist who is active in the effective altruism space.","news_type":1},"isVote":1,"tweetType":1,"viewCount":416,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":633780783,"gmtCreate":1644324458333,"gmtModify":1644324458333,"author":{"id":"3581829028595571","authorId":"3581829028595571","name":"lxy888","avatar":"https://static.tigerbbs.com/8f76391025cd7af92eae3c5e1195b9ef","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>a stock to buy and monitor","listText":"<a href=\"https://laohu8.com/S/ES3.SI\">$STI ETF(ES3.SI)$</a>a stock to buy and monitor","text":"$STI ETF(ES3.SI)$a stock to buy and monitor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633780783","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}